首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Systematic Elucidation of the Mechanism of Sappan Lignum in the Treatment of Diabetic Peripheral Neuropathy Based on Network Pharmacology
【24h】

Systematic Elucidation of the Mechanism of Sappan Lignum in the Treatment of Diabetic Peripheral Neuropathy Based on Network Pharmacology

机译:基于网络药理学治疗糖尿病外周神经病治疗的系统性阐释

获取原文
           

摘要

Background . Diabetic peripheral neuropathy (DPN) is one of the most common chronic complications of diabetes, which seriously affects the physical and mental health of patients. Sappan Lignum (SL) is effective in treating DPN. Previous reports have shown that SL has a clear hypoglycemic and anti-inflammatory effect. However, the study of SL in the treatment of DPN is still limited and rare. Objective . To investigate the mechanism of SL in the treatment of DPN based on network pharmacology. Methods . The active ingredients of SL were screened by related databases. The compound targets were collected by the target prediction platforms. The DPN-related targets were gathered through disease databases. The intersection targets were obtained by uploading the compound targets and disease targets to Venny 2.1.0, and a compound-target network was constructed by Cytoscape3.7.2. The protein-protein interaction (PPI) relationships were obtained by the STRING11.0 database. Genome Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed using the DAVID6.8 database. Molecular docking of key compounds and core targets was performed by DockThor. Results . A total of 29 compounds and 51 intersection targets with potential therapeutic effects on DPN were obtained. The compound-target network construction resulted in four key compounds: protostemonine, 3-deoxysappanchalcone, 7,3′,4′-trihydroxy-3-benzyl-2H-chromene, and o-12′-methylergocornine. PPI network analysis yielded 10 core targets: AKT1, MAPK3, CXCL8, TNF, OPRM1, MTOR, STAT3, MAPK8, SIRT1, and HSP90AA1. KEGG analysis resulted in 82 signaling pathways ( ), including insulin resistance, HIF-1 signaling pathway, and type II diabetes. The docking results indicated that the main active compounds could stably bind to core targets. Conclusion . SL had the mechanism of multiple ingredients, multiple targets, and multiple pathways in the treatment of DPN. This study provided a scientific basis for further research on the treatment of DPN with SL and its extracts.
机译:背景 。糖尿病外周神经病变(DPN)是糖尿病最常见的慢性并发症之一,这严重影响了患者的身心健康。 Sappan Lignum(SL)有效地治疗DPN。以前的报道表明,SL具有明显的降血糖和抗炎作用。然而,在DPN治疗中的SL研究仍然有限和罕见。客观的 。探讨基于网络药理学治疗DPN的SL的机制。方法 。通过相关数据库筛选SL的活性成分。通过目标预测平台收集化合物靶标。 DPN相关的目标通过疾病数据库收集。通过将化合物靶和疾病靶向上传到venny 2.1.0来获得交叉靶,并通过Cytoscape3.7.2构建复合靶网络。通过String11.0数据库获得蛋白质 - 蛋白质相互作用(PPI)关系。使用DAVID6.8数据库进行基因组本体(GO)和基因组(KEGG)分析的基因组(GO)和京都百科全书。通过段进行关键化合物和核心靶标的分子对接。结果 。获得了总共29种化合物和51个与DPN潜在治疗效果的交叉靶。复合靶网络施工导致四个关键化合物:淀粉素,3-脱氧巨蜥,7,3',4'-三羟基-3-苄基-2H-铬烯和O-12'-甲基庚烷。 PPI网络分析产生了10个核心目标:AKT1,MAPK3,CXCL8,TNF,OPRM1,MTOR,STAT3,MAPK8,SIRT1和HSP90AA1。 Kegg分析导致82个信号传导途径(),包括胰岛素抵抗,HIF-1信号通路和II型糖尿病。对接结果表明主要活性化合物可以稳定地与核心靶标结合。结论 。 SL在治疗DPN时具有多种成分,多种靶标和多种途径的机制。本研究为进一步研究DPN与SL及其提取物进行了科学依据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号